Commerzbank Aktiengesellschaft / Key word(s): Miscellaneous 29.09.2016 10:33 Disclosure of an inside information according to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- In response to current market rumours, the Board of Managing Directors of Commerzbank AG confirms that it has presented Commerzbank's draft strategic and financial objectives until 2020 to the Supervisory Board for consideration. No decision has yet been taken with regard to the implementation of these objectives. The Board of Managing Directors will decide tomorrow on the strategic objectives after discussions with the Supervisory Board. The objectives presented are as follows: By the end of 2020 Commerzbank will have sustainably increased its profitability. As part of the "Commerzbank 4.0" strategy, it will concentrate on its core businesses, digitalise 80% of relevant processes, and thereby achieve significant efficiency gains. Its business will be focused in two customer segments, "Private and Small Business Customers" and "Corporate Clients". The Mittelstandsbank and Corporates & Markets segments will be merged and trading activities in investment banking scaled back. This will reduce earnings volatility and regulatory risk and will free up capital to be invested in core client businesses. In the context of the decision of the new strategy, goodwill and intangible assets of both Corporates & Markets and Mittelstandsbank will be subjected to an impairment test. This means that most probably around 700 million euros would be written off in the third quarter of 2016. Consequently, the net result would be negative in the third quarter. The write-offs do not affect the Common Equity Tier 1 (CET 1) ratio. In terms of Operating profit, Commerzbank is expecting revenues to be approximately the same as in the second quarter. Loan loss provisions will be considerably higher than in the first two quarters due to ongoing weakness in the shipping markets. Despite the goodwill write-offs, Commerzbank is expecting a small net profit for 2016 as a whole. The CET 1 ratio after full application of Basel 3 will be higher in the third quarter of 2016 than in the previous quarter. The Bank is expecting its Common Equity Tier 1 ratio to stand at nearly 12% at the end of the year, provided no significant market distortions occur. Commerzbank is aiming for a net return on tangible equity (RoTE) of at least 6% by the end of 2020. This target is based on the expectation that the interest rate environment will remain challenging. Should the interest rate environment improve, a net return on tangible equity of at least 8% will be achievable. Commerzbank is expecting revenues for 2020 to total between 9.8 and 10.3 billion euros. The cost base is to be reduced to 6.5 billion euros, taking the cost/income ratio to below 66%. In a normalised interest rate environment, revenues could rise to over 11 billion euros and the cost/income ratio could fall to around 60%. The Common Equity Tier 1 (CET 1) ratio, after full application of Basel 3, is expected to stay at around 12% and will be above 12% in 2018 taking into account currently foreseeable regulatory developments. For 2020 the Bank expects a ratio of above 13%. The focus on the core business, with some business activities being discontinued, and the digitalisation and automation of workflows will lead to staff reductions amounting to around 9,600 full-time positions. The Bank will shortly begin preparatory discussions with the relevant employee representative committees. At the same time, around 2,300 new jobs will be created in areas of business growth. Hence the net number of jobs shed will amount to around 7,300 full-time positions. To cover its restructuring costs in the region of 1.1 billion euros, Commerzbank will cease dividend payments for the time being and will retain its full earnings. ***** Disclaimer This release contains forward-looking statements. Forward-looking statements are statements that are not historical facts. In this release, these statements concern inter alia the expected future business of Commerzbank, efficiency gains and expected synergies, expected growth prospects and other opportunities for an increase in value of Commerzbank as well as expected future financial results, restructuring costs and other financial developments and information. These forward-looking statements are based on the management's current plans, expectations, estimates and projections. They are subject to a number of assumptions and involve known and unknown risks, uncertainties and other factors that may cause actual results and developments to differ materially from any future results and developments expressed or implied by such forward-looking statements. Such factors include the conditions in the financial markets in Germany, in Europe, in the USA and other regions from which Commerzbank derives a substantial portion of its revenues and in which Commerzbank holds a substantial portion of its assets, the development of asset prices and market volatility, especially due to the ongoing European debt crisis, potential defaults of borrowers or trading counterparties, the implementation of its strategic initiatives to improve its business model, particularly to reduce its ACR portfolio, the reliability of its risk management policies, procedures and methods, risks arising as a result of regulatory change and other risks. Forward-looking statements therefore speak only as of the date they are made. Commerzbank has no obligation to update or release any revisions to the forward-looking statements contained in this release to reflect events or circumstances after the date of this release. Contact: Commerzbank AG Group Communications Tel.: +49 69 136 - 22830 mediarelations@commerzbank.com 29.09.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: Commerzbank Aktiengesellschaft Kaiserstraße 16 60311 Frankfurt am Main Germany Phone: +49 (069) 136 20 Fax: - E-mail: pressestelle@commerzbank.com Internet: www.commerzbank.de ISIN: DE000CBK1001 WKN: CBK100 Indices: DAX, CDAX, HDAX, PRIMEALL Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich, Stuttgart; Regulated Unofficial Market in Tradegate Exchange; London, SIX End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Commerzbank: Board of Managing Directors
Top 10 Most Recent News Articles
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control
Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...
Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win
Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...
Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes
A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...
Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage
The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...
Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment
Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...
Continue Reading
Local Voices to Shape Mekong's Story in New Alliance
Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...
Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech
Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...
Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal
Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...
Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup
An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....
Continue ReadingTop 5 Most Recently Viewed Articles
Discover the Game-Changing Trends Transforming Food Choices
Nourish Food Marketing Unveils Influential Trends for 2025 Nourish Food Marketing, a dynamic agency specializing in the food, beverage, and agriculture sector, recently unveiled its 9th annual Trend Report for 2025. This insightful report dives deep into nine major trends that will not only shape the industry but will also significantly influence consumer behavior in the...
Continue Reading
Investigation into Sezzle Inc. Over Securities Concerns
Introduction to Sezzle Inc. Investigation Sezzle Inc. is currently under investigation by the Portnoy Law Firm, a notable name in securities litigation. This inquiry centers around potential securities fraud that may impact investors significantly. For those with concerns about their investments in Sezzle, it's important to understand the details surrounding this...
Continue Reading
Conagra Brands Sees Analyst Revisions Post Mixed Performance
Conagra Brands Experiences Uneven Results in Latest Quarter Conagra Brands Inc (NYSE: CAG) has faced a challenging environment, reflecting a mixed performance in its latest quarterly results. The company reported earnings of 45 cents per share for the quarter, slightly surpassing expectations that predicted 44 cents per share. However, the revenue aspect did not align as...
Continue Reading
CNOOC Limited Achieves Record Oil and Gas Production Growth
CNOOC Limited Achieves New Milestones in Oil and Gas Production CNOOC Limited has unveiled impressive operational results, marking a significant increase in oil and gas production. The company's dedication to strategic growth has propelled it to a record-breaking first half of 2025. As production metrics shine, CNOOC Limited (SEHK: 00883 (HKD Counter) and 80883 (RMB...
Continue Reading
Growth Prospects of the Automotive Bearing Market Ahead
Understanding the Automotive Bearing Market Growth The global Automotive Bearing Market is experiencing remarkable growth, spurred by the rapid adoption of electric vehicles (EVs), advances in lightweight materials, and an increasing emphasis on fuel efficiency. Despite facing challenges like fluctuating raw material prices, supply chain issues, and counterfeit products,...
Continue Reading